IT@UC to extend single sign-on window
Change scheduled for 7 a.m., Tuesday, March 17
Related Stories
UC expert weighs in on current MASH treatment approaches
June 5, 2026
As MedCentral recently reported, pending broader pharmacologic approvals for metabolic dysfunction-associated steatohepatitis (MASH), lifestyle modifications remain the go-to intervention.
UC expert explains how provocateurs try to manipulate conflict
June 4, 2026
UC Professor Jeffrey Blevins talks to the Dallas Morning News about how outside agitators seize on tragedy to push their agendas.
At least two weather patterns increase headaches, UC study suggests
June 4, 2026
University of Cincinnati physicians and collaborators identified two specific weather patterns that increase headache and migraine risk and found the preventive medication fremanezumab (Ajovy) can reduce weather‑associated headaches. The findings will be presented at the American Headache Society Annual Scientific Meeting in Orlando.